BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

514 related articles for article (PubMed ID: 28176480)

  • 1. De novo thrombotic microangiopathy following simultaneous pancreas and kidney transplantation managed with eculizumab.
    Shochet L; Kanellis J; Simpson I; Ta J; Mulley W
    Nephrology (Carlton); 2017 Feb; 22 Suppl 1():23-27. PubMed ID: 28176480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Eculizumab for the treatment of de novo thrombotic microangiopathy post simultaneous pancreas-kidney transplantation--a case report.
    Chandran S; Baxter-Lowe L; Olson JL; Tomlanovich SJ; Webber A
    Transplant Proc; 2011 Jun; 43(5):2097-101. PubMed ID: 21693335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two cases of kidney transplantation-associated thrombotic microangiopathy successfully treated with eculizumab.
    Ikeda T; Okumi M; Unagami K; Kanzawa T; Sawada A; Kawanishi K; Omoto K; Ishida H; Tanabe K
    Nephrology (Carlton); 2016 Jul; 21 Suppl 1():35-40. PubMed ID: 26970541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful conversion to belatacept after thrombotic microangiopathy in kidney transplant patients.
    Koppula S; Yost SE; Sussman A; Bracamonte ER; Kaplan B
    Clin Transplant; 2013; 27(4):591-7. PubMed ID: 23923969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful treatment of de novo posttransplant thrombotic microangiopathy with eculizumab.
    Wilson CH; Brown AL; White SA; Goodship TH; Sheerin NS; Manas DM
    Transplantation; 2011 Oct; 92(8):e42-3. PubMed ID: 21989273
    [No Abstract]   [Full Text] [Related]  

  • 6. Eculizumab for drug-induced de novo posttransplantation thrombotic microangiopathy: A case report.
    Safa K; Logan MS; Batal I; Gabardi S; Rennke HG; Abdi R
    Clin Nephrol; 2015 Feb; 83(2):125-9. PubMed ID: 24495904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isolated thrombotic microangiopathy of the small intestine in a patient with atypical hemolytic uremic syndrome - a case report.
    Nunius C; Büttner-Herold M; Bertz S; Schiffer M; Buchholz B
    BMC Nephrol; 2020 Mar; 21(1):104. PubMed ID: 32204691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complement inhibition with eculizumab for thrombotic microangiopathy rescues a living-donor kidney transplant in a patient with antiphospholipid antibody syndrome.
    Geethakumari PR; Mille P; Gulati R; Nagalla S
    Transfus Apher Sci; 2017 Jun; 56(3):400-403. PubMed ID: 28428030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytomegalovirus-induced thrombotic microangiopathy after renal transplant successfully treated with eculizumab: case report and review of the literature.
    Java A; Edwards A; Rossi A; Pandey R; Gaut J; Delos Santos R; Miller B; Klein C; Brennan D
    Transpl Int; 2015 Sep; 28(9):1121-5. PubMed ID: 25864519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thrombotic Microangiopathy Following Pediatric Autologous Hematopoietic Cell Transplantation: A Report of Significant End-Organ Dysfunction in Eculizumab-Treated Survivors.
    Schoettler M; Lehmann L; Li A; Ma C; Duncan C
    Biol Blood Marrow Transplant; 2019 May; 25(5):e163-e168. PubMed ID: 30639820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombotic Microangiopathy as a Cause of Chronic Kidney Transplant Dysfunction: Case Report Demonstrating Successful Treatment with Eculizumab.
    Iqbal Z; Wood K; Carter V; Goodship TH; Brown AL; Sheerin NS
    Transplant Proc; 2015 Sep; 47(7):2258-61. PubMed ID: 26361694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eculizumab in acute recurrence of thrombotic microangiopathy after renal transplantation.
    Hadaya K; Ferrari-Lacraz S; Fumeaux D; Boehlen F; Toso C; Moll S; Martin PY; Villard J
    Am J Transplant; 2011 Nov; 11(11):2523-7. PubMed ID: 21831149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [De novo hemolytic uremic syndrome in a kidney-pancreas recipient in the postoperative period].
    Gutiérrez de la Fuente C; Sola E; Alférez MJ; Navarro A; Cabello M; Burgos D; González Molina M
    Nefrologia; 2004; 24 Suppl 3():3-6. PubMed ID: 15219059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of eculizumab in a systemic lupus erythemathosus patient presenting thrombotic microangiopathy and heterozygous deletion in CFHR1-CFHR3. A case report and systematic review.
    de Holanda MI; Pôrto LC; Wagner T; Christiani LF; Palma LMP
    Clin Rheumatol; 2017 Dec; 36(12):2859-2867. PubMed ID: 28905254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of Eculizumab in Patients With Allogeneic Stem Cell Transplant-Associated Thrombotic Microangiopathy: A Study From the SFGM-TC.
    de Fontbrune FS; Galambrun C; Sirvent A; Huynh A; Faguer S; Nguyen S; Bay JO; Neven B; Moussi J; Simon L; Xhaard A; Resche-Riggon M; O'Meara A; Fremeaux-Bacchi V; Veyradier A; Socié G; Coppo P; de Latour RP
    Transplantation; 2015 Sep; 99(9):1953-9. PubMed ID: 25651309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Eculizumab in Transplant-Associated Thrombotic Microangiopathy.
    Dhakal P; Giri S; Pathak R; Bhatt VR
    Clin Appl Thromb Hemost; 2017 Mar; 23(2):175-180. PubMed ID: 26259912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Variable Eculizumab Clearance Requires Pharmacodynamic Monitoring to Optimize Therapy for Thrombotic Microangiopathy after Hematopoietic Stem Cell Transplantation.
    Jodele S; Fukuda T; Mizuno K; Vinks AA; Laskin BL; Goebel J; Dixon BP; Chima RS; Hirsch R; Teusink A; Lazear D; Lane A; Myers KC; Dandoy CE; Davies SM
    Biol Blood Marrow Transplant; 2016 Feb; 22(2):307-315. PubMed ID: 26456258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [De novo thombotic microangiopathy (TMA) after incompatible AB0 renal transplantation].
    Kolb T; Rump LC
    Dtsch Med Wochenschr; 2021 Apr; 146(8):530-533. PubMed ID: 33853171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A 'silent', new polymorphism of factor H and apparent de novo atypical haemolytic uraemic syndrome after kidney transplantation.
    Broeders EN; Stordeur P; Rorive S; Dahan K
    BMJ Case Rep; 2014 Dec; 2014():. PubMed ID: 25538218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thrombotic microangiopathy after kidney transplantation: Analysis of the Brazilian Atypical Hemolytic Uremic Syndrome cohort.
    Nga HS; Palma LMP; Ernandes Neto M; Fernandes-Charpiot IMM; Garcia VD; Kist R; Miranda SMC; Macedo de Souza PA; Pereira GM; de Andrade LGM
    PLoS One; 2021; 16(11):e0258319. PubMed ID: 34748552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.